Sec Form 4 Filing - VAN OORT DOUGLAS M @ BIOHITECH GLOBAL, INC. - 2017-08-17

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person VAN OORT DOUGLAS M 2. Issuer Name and Ticker or Trading Symbol BIOHITECH GLOBAL, INC. [ BHTG] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) C/O BIOHITECH GLOBAL, INC., 80 RED SCHOOLHOUSE ROAD, SUITE 101 3. Date of Earliest Transaction (MM/DD/YY) 08/17/2017 (Street) CHESTNUT RIDGE, NY10972 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) _____ Form filed by One Reporting Person __ X __ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price

36,364 Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Convertible Promissory Note $ 2.75 ( 1 ) 08/17/2017 X 1 08/17/2017 07/06/2019 Common Stock 36,364 ( 2 ) $ 100,000 1 ( 3 ) I Held by Conundrum Capital Partners, LLC Warrants $ 3.3 ( 4 ) 08/17/2017 X 08/17/2017 08/17/2022 Common Stock 36,364 ( 5 ) $ 0 36,364 I Held by Conundrum Capital Partners, LLC

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other VAN OORT DOUGLAS M C/O BIOHITECH GLOBAL, INC. 80 RED SCHOOLHOUSE ROAD, SUITE 101 CHESTNUT RIDGE, NY10972 X CONUNDRUM CAPITAL PARTNERS, LLC 317 EATONS LANDING DRIVE ANNAPOLIS, MD21401 X Signatures /s/ Douglas M. VanOort 08/22/2017 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Represents the highest possible conversion price of the note. ( 2 )Represents the number of shares of common stock, par value $$0.0001 per share ("Common Stock") into which the note is convertible based on the conversion price of $2.75 per share. The note is convertible into an indeterminable number of shares. ( 3 )Does not include 837,296 shares held by Conundrum Capital Partners, LLC ("Conundrum") over which Mr. VanOort holds voting and dispositive power. The address of Conundrum is 317 Eatons Landing Drive, Annapolis, MD 21401. ( 4 )Based on 120% of the conversion price of $2.75 per share. The warrants are exercisable into an indeterminable number of shares. ( 5 )Represents the number of shares of Common Stock into which the warrants are exercisable based on the exercise price of $3.30 per share.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.